|
Federal
Register Notices >
Notices of Application - 2003 > Cerrilliant Corporation
FR Doc 03-2914
[Federal Register: February 6, 2003 (Volume 68, Number 25)]
[Notices]
[Page 6182-6183]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06fe03-84]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of
Application
Pursuant to Sec.
1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this
is notice that on July 31, 2002, Cerrilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78664, made application by renewal to
the Drug Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| 4-Methylaminorex (cis isomer)
(1590) |
I |
| Gamma hydroxybutyric acid (2010) |
I |
| Methaqualone (2565) |
I |
| Alpha-Ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide (7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine
(7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine
(7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine
(7392) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine
(7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine
(7399) |
I |
| 3,4-Methylenedioxyamphetamine
(7400) |
I |
| 5-Methoxy-3,4-methylenedioxyamphetamine
(7401) |
I |
| N-Hydroxy-3,4-methylenedioxyamphetamine
(7402) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine
(7404) |
I |
| 3,4-Methylenedioxymethamphetamine
(7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| Bufotenine (7433) |
I |
| Diethyltryptamine (7434) |
I |
| Dimethyltryptamine (7435) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| Acetyldihydrocodeine (9051) |
I |
| Benzylmorphine (9052) |
I |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Heroin (9200) |
I |
| Hydromorphinol (9301) |
I |
| Methyldihydromorphine (9304) |
I |
| Morphine-N-oxide (9307) |
I |
[[Page 6183]]
| Drug |
Schedule |
| Normorphine (9313) |
I |
| Pholcodine (9314) |
I |
| Acetylmethadol
(9601) |
I |
| Allyprodine (9602) |
I |
| Alphacetylmethadol
except Levo-Alphacetylmethadol (9603) |
I |
| Alphameprodine
(9604) |
I |
| Alphamethadol (9605) |
I |
| Betacetylmethadol
(9607) |
I |
| Betameprodine (9608) |
I |
| Betamethadol (9609) |
I |
| Betaprodine (9611) |
I |
| Hydromorphinol
(9627) |
I |
| Noracymethadol
(9633) |
I |
| Norlevorphanol
(9634) |
I |
| Normethadone (9635) |
I |
| Trimeperidine (9646) |
I |
| Phenomorphan (9647) |
I |
| Para-Fluorofentanyl
(9812) |
I |
| 3-Methylfentanyl
(9813) |
I |
| Alpha-methylfentanyl
(9814) |
I |
| Acetyl-alpha-methylfentanyl
(9815) |
I |
| Beta-hydroxyfentanyl
(9830) |
I |
| Beta-hydroxy-3-methylfentanyl
(9831) |
I |
| Alpha-Methylthiofentanyl
(9832) |
I |
| 3-Methylthiofentanyl
(9833) |
I |
| Thiofentanyl (9835) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine
(1105) |
II |
| Phenmetrazine (1631) |
II |
| Methylphenidate
(1724) |
II |
| Amobarbital (2125) |
II |
| Pentabarbital (2270) |
II |
| Secobarbital (2315) |
II |
| Glutethimide (2550) |
II |
| Nabilone (7379) |
II |
| 1-Phenylcyclohexylamine
(7460) |
II |
| Phencyclidine (7471) |
II |
| 1-Piperidinocyclohexanecarbonitrile
(8603) |
II |
| Alphaprodine (9010) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine
(9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine
(9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Levomethorphan
(9210) |
II |
| Levorphanol (9220) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone-intermediate
(9254) |
II |
| Dextropropoxyphene,
bulk (non-dosage forms) (9273). |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol
(9648) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone
(9668) |
II |
| Racemethorphan
(9732) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The firm plans to manufacture small quantities of
the listed controlled substances to make deuterated and non-deuterated
drug reference standards which will be distributed to analytical and
forensic laboratories for drug testing programs.
Any other such applicant and nay person who is
presently registered with DEA to manufacture such substances may file
comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in
quintuplicate, to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, DC 20537, Attention: DEA Federal Register
Representative (CCR), and must be filed no later than April 7, 2003.
Dated: January 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-2914 Filed 2-5-03; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
